Laddar...
High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
Immunotherapies have dramatically improved survival outcome for patients with melanoma. MUC16 encodes cancer antigen 125 (CA125), which is frequently mutated in melanoma. In this study, we correlated the MUC16 mutational status with the following: tumor mutation burden (TML), multiple immune-related...
Sparad:
| I publikationen: | Aging (Albany NY) |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7346065/ https://ncbi.nlm.nih.gov/pubmed/32491995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103296 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|